增强现实联合吲哚菁绿荧光成像引导中央型肝细胞癌肝切除术的围术期与无病生存结局
本研究为一项非随机临床试验的事后分析,连续纳入76例中央型肝细胞癌患者,其中42例接受增强现实导航联合荧光成像(ARN-FI)引导的腹腔镜肝切除术,34例未使用该引导。结果显示ARN-FI组术中出血量、输血率、术后住院时间和并发症率均更低,但两组无病生存无显著差异。
要点
- ARN-FI引导可减少中央型肝细胞癌腹腔镜肝切除术的术中出血和输血。
- ARN-FI引导可缩短术后住院时间并降低术后并发症发生率。
- 两组总体无病生存无显著差异,围术期无死亡。
核心结论
- ARN-FI可能有助于提高中央型肝细胞癌腹腔镜肝切除术的成功率、减少并发症、加速康复并缩短住院时间。
研究设计与样本
- 原始非随机临床试验的事后分析,2018年6月至2021年6月连续纳入76例患者,ARN-FI组42例,非ARN-FI组34例。
主要发现
- ARN-FI组术中出血量中位数275 mL,非ARN-FI组300 mL(p=0.013)。
- ARN-FI组术中输血率14.3%,非ARN-FI组64.7%(p<0.01)。
- ARN-FI组术后住院时间中位数8天,非ARN-FI组9天(p=0.005)。
- ARN-FI组术后并发症率35.7%,非ARN-FI组61.8%(p=0.024)。
- 两组总体无病生存无显著差异(p=0.16),围术期及随访期无死亡。
临床怎么用
- 对于中央型肝细胞癌的腹腔镜肝切除术,可考虑使用ARN-FI引导以改善围术期结局。
局限性
- 本研究为非随机临床试验的事后分析,样本量有限,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic hepatectomy for centrally located hepatocellular carcinoma is challenging to perform. Augmented reality navigation (ARN) and fluorescence imaging are currently safe and reproducible techniques for hepatectomy, but the efficacy results for centrally located hepatocellular carcinoma have not been reported. This study aimed to evaluate the efficacy of an ARN system combined with fluorescence imaging (ARN-FI) in laparoscopic hepatectomy for centrally located hepatocellular carcinoma. STUDY DESIGN: This was a post hoc analysis of an original nonrandomized clinical trial that was designed to evaluate the feasibility and efficacy of ARN-FI for laparoscopic liver resection. A total of 76 patients were consecutively enrolled from June 2018 to June 2021, of which 42 underwent laparoscopic hepatectomy using ARN-FI (ARN-FI group), and the other 34 who did not use ARN-FI guidance (non-ARN-FI group). Perioperative outcomes and disease-free survival were compared between the 2 groups. RESULTS: Compared with the non-ARN-FI group, the ARN-FI group had less intraoperative blood loss (median 275 vs 300 mL, p = 0.013), lower intraoperative transfusion rate (14.3% vs 64.7%, p < 0.01), shorter postoperative hospital stay (median 8 vs 9 days, p = 0.005), and lower postoperative complication rate (35.7% vs 61.8%, p = 0.024). There was no death in the perioperative period and follow-up period. There was no significant difference in overall disease-free survival between the 2 groups (p = 0.16). CONCLUSIONS: The ARN system and fluorescence imaging may be of value in improving the success rate of surgery, reducing postoperative complications, accelerating postoperative recovery, and shortening postoperative hospital stay.
引用
- Zhu W, Zeng X, Hu H, et al. Perioperative and Disease-Free Survival Outcomes after Hepatectomy for Centrally Located Hepatocellular Carcinoma Guided by Augmented Reality and Indocyanine Green Fluorescence Imaging: A Single-Center Experience. J Am Coll Surg. 2022. PMID: 36648260. doi:10.1097/XCS.0000000000000472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。